drugset

drugset / Trial / NCT03160807

Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections

NCT03160807 ↗

Phase 4 Unknown 214 enrolled Dr. Reddy's Laboratories Limited

RandomizedParallel-groupOpen-labelTreatment

Summary

Study is planned to evaluate safety and efficacy of Levolet in patients with complicated UTI

Timeline

Start: 2017-04-15
Primary completion: 2018-03
Completion: 2018-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Levofloxacin	Small molecule	500 mg	—

Indications